Skip to main content
Caplight Logo









Deliberate AI

Deliberate AI

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.deliberate.ai/

Last Round

Seed

Jun 11, 2026

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Deliberate AI is a healthcare technology company that develops regulatory-grade, precision measurement technology for mental and neurological health care using multimodal artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Clinical Trials, Computer Vision, Mental Health, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical AIcomputer visionbehavioral healthclinical trialsdigital biomarkersmental health techhealth techclinical assessmentmultimodal AIpatient monitoringAI-COAclinical outcome assessmentbiomarker discoverymedtechhealthcare analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deliberate AI Comparables

Compare Deliberate AI with similar companies based on industry and business-model similarity.

Deliberate AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Storyline Health
84%
Altoida, Inc.
80%
AiCure
78%

Deliberate AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 11, 2026
AcceleratorFeb 21, 2025
AcceleratorMar 21, 2022

Key People

Founding team and executive leadership

Marc Aafjes

Founder & CEO

Founding Team

Deliberate AI Investors

Notable investors and investment history

Deliberate AI investors
InvestorRounds
Scribble VenturesSeed
PharmStarsAccelerator
One MindAccelerator
Bessemer Venture PartnersSeed
Kleiner PerkinsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Grew 50% QoQ from 8 to 12 employees.

  • Jun 11, 2026

    Raised capital from Kleiner Perkins and Bessemer Venture Partners.

Deliberate AI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Deliberate AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Deliberate AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range12
Year Founded2020
Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?